<p>Santen Pharmaceutical Co., Ltd. announced the repurchase of a total of 19,646,600 common shares for approximately 31.7 billion yen. The buyback was conducted via open-market discretionary trading as part of a program authorized by the company’s Board of Directors. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Santen Pharmaceutical Co. Ltd. published the original content used to generate this news brief on November 04, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

SNPHY

<p>Santen Pharmaceutical Co., Ltd. has completed a share buyback of 19,646,600 common shares, totaling approximately 31.7 billion yen. This buyback was executed through open-market discretionary trading, following authorization from the company's Board of Directors.</p>

Santen Pharmaceutical completes share buyback totaling 31,663,080,500 yen